Accordingly, overexpression of TARBP2 decreased the level of sorafenib resistance in PLC5/SR cells (Fig. 2C,D), suggesting that TARBP2 functions as a tumor suppressor by sensitizing = HCC cells to sorafenib treatment. Here, TARBP2 is linked to neoplasm.